World's Best Scientists 2026 revealed!
Edward V. Loftus

Edward V. Loftus

D-Index & Metrics

Medicine

D-Index
137
Citations
78395
World Ranking
1895
National Ranking
1075

Overview

Edward V. Loftus is affiliated with the Mayo Clinic in the United States. Their research primarily focuses on areas within medicine, particularly related to inflammatory and autoimmune disorders.

The scientist has an extensive publication record, contributing to fields including Medicine and Biochemistry, Genetics, and Molecular Biology. Subfields of study include Genetics, Epidemiology, Surgery, Immunology, and Gastroenterology.

Loftus's main topics of work encompass:

  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Eosinophilic Esophagitis
  • Immunodeficiency and Autoimmune Disorders
  • Autoimmune and Inflammatory Disorders
  • Biosimilars and Bioanalytical Methods
  • Liver Diseases and Immunity

Their recent notable publications include:

  • "Upadacitinib Induction and Maintenance Therapy for Crohn's Disease", 2023, New England Journal of Medicine
  • "Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials", 2022, The Lancet
  • "Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials", 2022, The Lancet
  • "Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial", 2021, The Lancet
  • "Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease", 2020, Gastroenterology

Frequent co-authors collaborating with Loftus include:

  • Silvio Danese
  • Remo Panaccione
  • Geert D'Haens
  • Laurent Peyrin-Biroulet
  • Séverine Vermeire

Their work appears in key publication venues, notably:

  • Gastroenterology
  • The American Journal of Gastroenterology
  • Journal of Crohn's and Colitis
  • Inflammatory Bowel Diseases
  • Clinical Gastroenterology and Hepatology

Best Publications

  • Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

    Mark S. Silverberg;Jack Satsangi;Tariq Ahmad;Ian D. R. Arnott

  • Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences

    Edward V Loftus

  • Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

    L. Peyrin-Biroulet;W. Sandborn;B. E. Sands;W. Reinisch;W. Reinisch

  • The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study

    William A. Faubion;Edward V. Loftus;William S. Harmsen;Alan R. Zinsmeister

  • The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota.

    David A. Schwartz;Edward V. Loftus;William J. Tremaine;Remo Panaccione

  • Risk factors for opportunistic infections in patients with inflammatory bowel disease.

    Murat Toruner;Edward V. Loftus;W. Scott Harmsen;Alan R. Zinsmeister

  • ACG Clinical Guideline: Management of Crohn’s Disease in Adults

    Gary R Lichtenstein;Edward V Loftus;Kim L Isaacs;Miguel D Regueiro

  • The safety profile of infliximab in patients with Crohn's disease: The Mayo Clinic experience in 500 patients

    Jean Frederic Colombel;Edward V. Loftus;William J. Tremaine;Laurence J. Egan

  • The Natural History of Adult Crohn's Disease in Population-Based Cohorts

    Laurent Peyrin-Biroulet;Edward V. Loftus;Jean Frederic Colombel;William J. Sandborn

  • Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort.

    Kelvin T. Thia;Kelvin T. Thia;William J. Sandborn;William S. Harmsen;Alan R. Zinsmeister

  • Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000

    Conor G. Loftus;Edward V. Loftus;W. Scott Harmsen;Alan R. Zinsmeister

  • The safety of vedolizumab for ulcerative colitis and Crohn's disease

    Jean Frédéric Colombel;Bruce E. Sands;Paul Rutgeerts;William Sandborn

  • PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis

    E V Loftus;G C Harewood;C G Loftus;W J Tremaine

  • Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival.

    Edward V. Loftus;Marc D. Silverstein;Marc D. Silverstein;William J. Sandborn;William J. Tremaine

  • Correlation of C‐reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease

    Craig A Solem;Edward V Loftus;William J Tremaine;William S Harmsen

  • An update on the epidemiology of inflammatory bowel disease in Asia.

    Kelvin T. Thia;Edward V. Loftus;William J. Sandborn;Suk Kyun Yang

  • Development of the Crohn's disease digestive damage score, the Lémann score†‡§

    Benjamin Pariente;Jacques Cosnes;Silvio Danese;William J. Sandborn

  • Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

    Darell S. Pardi;Edward V. Loftus;Walter K. Kremers;Jill C. Keach

  • Epidemiology of inflammatory bowel disease

    Edward V Loftus;William J Sandborn

  • Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival.

    E V Loftus;M D Silverstein;W J Sandborn;W J Tremaine

Frequent Co-Authors

William J. Sandborn
William J. Sandborn University of California, San Diego
Jean-Frederic Colombel
Jean-Frederic Colombel Icahn School of Medicine at Mount Sinai
Siddharth Singh
Siddharth Singh University of California, San Diego
Bruce E. Sands
Bruce E. Sands Icahn School of Medicine at Mount Sinai
Remo Panaccione
Remo Panaccione University of Calgary
Brian G. Feagan
Brian G. Feagan University of Western Ontario
Joel G. Fletcher
Joel G. Fletcher Mayo Clinic
Laurent Peyrin-Biroulet
Laurent Peyrin-Biroulet University of Lorraine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medical careers but looking for flexible or alternative educational options, there are many promising online degree pathways available. These opportunities can open doors to a variety of roles within healthcare, from direct patient care to administration and nutrition.

If you are eager to enter the nursing profession but want to avoid lengthy pre-admission testing, consider nursing schools that don't require teas. These programs allow students to start their nursing education without the need for traditional entrance exams, making the process more accessible.

Those aspiring to move quickly into leadership roles may benefit from a healthcare administration degree offered in an accelerated format online. This pathway prepares graduates for management positions in hospitals, clinics, and other healthcare organizations.

Registered nurses aiming to advance their qualifications can explore asn to nurse practitioner programs, which provide a bridge from an associate's degree in nursing to a master’s level credential, enabling enhanced practice opportunities.

Finally, students interested in preventive health and wellness can pursue online nutrition degree programs. These programs can lead to careers in dietetics, nutrition counseling, and health education.

Best Scientists Citing Edward V. Loftus

Trending Scientists

Recently Published Articles